The nitric oxide-donor molsidomine modulates the innate inflammatory response in a mouse model of muscular dystrophy

European Journal of Pharmacology

Volumn 715, Issue 1-3, 2013, Pages 296-303

  Zordan, Paola ^a   Sciorati, Clara ^a   Campana, Lara ^a   Cottone, Lucia ^a   Clementi, Emilio ^b,c   Querini, Patrizia Rovere ^a   Brunelli, Silvia ^a,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Macrophages; Molsidomine; Muscular dystrophy; Nitric oxide; Sarcoglican

Indexed keywords

MOLSIDOMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE COURSE; FIBROSIS; HEALING; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; MACROPHAGE; MOUSE; MUSCLE ATROPHY; MUSCLE INJURY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; TISSUE PRESERVATION;

MACROPHAGES; MOLSIDOMINE; MUSCULAR DYSTROPHY; NITRIC OXIDE; Α-SARCOGLICAN;

ANIMALS; DISEASE MODELS, ANIMAL; FIBROSIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; MOLSIDOMINE; MUSCULAR DYSTROPHIES; NITRIC OXIDE; PHENOTYPE;

EID: 84885483185     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.05.007     Document Type: Article

References (50)

1. Agvald, P., Adding, L.C., Gustafsson, L.E., Persson, M.G., 1999. Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo. Eur. J. Pharmacol. 385, 137-145.
2. Anderson, J.E., 2000. A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol. Biol. Cell 11, 1859-1874. (Pubitemid 30307918)
3. Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R.K., Chazaud, B., 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204, 1057-1069. (Pubitemid 46798150)
4. Barton, E.R., Morris, L., Kawana, M., Bish, L.T., Toursel, T., 2005. Systemic administration of L-arginine benefits mdx skeletal muscle function. Muscle Nerve 32, 751-760. (Pubitemid 41746263)
5. Baudry, C., 1982. The antianginal effect of molsidomine in prolonged oral therapy. A double blind, crossover, randomized study. Acta Cardiol. 37, 23-30. (Pubitemid 12119992)
6. Bogdan, C., 2001. Nitric oxide and the immune response. Nat. Immunol. 2, 907-916. (Pubitemid 32976162)
7. Bosurgi, L., Corna, G., Vezzoli, M., Touvier, T., Cossu, G., Manfredi, A.A., Brunelli, S., Rovere-Querini, P., 2012. Transplanted mesoangioblasts require macrophage IL-10 for survival in a mouse model of muscle injury. J. Immunol 188, 6267-6277.
8. Brenman, J.E., Chao, D.S., Xia, H., Aldape, K., Bredt, D.S., 1995. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82, 743-752.
9. Brunelli, S., Rovere-Querini, P., 2008. The immune system and the repair of skeletal muscle. Pharmacol. Res. 58, 117-121.
10. Brunelli, S., Sciorati, C., D'Antona, G., Innocenzi, A., Covarello, D., Galvez, B.G., Perrotta, C., Monopoli, A., Sanvito, F., Bottinelli, R., Ongini, E., Cossu, G., Clementi, E., 2007. Nitric oxide release combined with nonsteroidal antiin-flammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc. Natl. Acad. Sci. USA 104, 264-269. (Pubitemid 46068020)
11. Buono, R., Vantaggiato, C., Pisa, V., Azzoni, E., Bassi, M.T., Brunelli, S., Sciorati, C., Clementi, E., 2012. Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP. Stem Cells 30, 197-209.
12. Chang, W.J., Iannaccone, S.T., Lau, K.S., Masters, B.S., McCabe, T.J., McMillan, K., Padre, R.C., Spencer, M.J., Tidball, J.G., Stull, J.T., 1996. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc. Natl. Acad. Sci. USA 93, 9142-9147. (Pubitemid 26282032)
13. Coletti, D., Moresi, V., Adamo, S., Molinaro, M., Sassoon, D., 2005. Tumor necrosis factor-alpha gene transfer induces cachexia and inhibits muscle regeneration. Genesis 43, 120-128. (Pubitemid 41780911)
14. Corna, G., Campana, L., Pignatti, E., Castiglioni, A., Tagliafico, E., Bosurgi, L., Campanella, A., Brunelli, S., Manfredi, A.A., Apostoli, P., Silvestri, L., Camaschella, C., Rovere-Querini, P., 2010. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 95, 1814-1822.
15. Crisafulli, C., Galuppo, M., Cuzzocrea, S., 2009. Effects of genetic and pharmacological inhibition of TNF-alpha in the regulation of inflammation in macrophages. Pharmacol. Res. 60, 332-340.
16. De Palma, C., Clementi, E., 2012. Nitric oxide in myogenesis and therapeutic muscle repair. Mol. Neurobiol. 46, 682-692.
17. Dendorfer, A., 1996. [Pharmacology of nitrates and other NO donors]. Herz 21 (Suppl. 1), 38-49. (Pubitemid 26195831)
18. Duclos, F., Straub, V., Moore, S.A., Venzke, D.P., Hrstka, R.F., Crosbie, R.H., Durbeej, M., Lebakken, C.S., Ettinger, A.J., van der Meulen, J., Holt, K.H., Lim, L.E., Sanes, J.R., Davidson, B.L., Faulkner, J.A., Williamson, R., Campbell, K.P., 1998. Progressive muscular dystrophy in alpha-sarcoglycan- deficient mice. J. Cell Biol. 142, 1461-1471. (Pubitemid 28452596)
19. Emery, A.E., 2002. The muscular dystrophies. Lancet 359, 687-695. (Pubitemid 34203773)
20. Filippin, L.I., Moreira, A.J., Marroni, N.P., Xavier, R.M., 2009. Nitric oxide and repair of skeletal muscle injury. Nitric Oxide.
21. Fung, H.L., 1993. Clinical pharmacology of organic nitrates. Am. J. Cardiol. 72, 9C-13C; discussion 14C-15C.
22. Galvez, B.G., Sampaolesi, M., Brunelli, S., Covarello, D., Gavina, M., Rossi, B., Constantin, G., Costantin, G., Torrente, Y., Cossu, G., 2006. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J. Cell Biol. 174, 231-243. (Pubitemid 44079858)
23. Gordon, S., Martinez, F.O., 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604.
24. Hickey, M.J., 2001. Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin. Sci. 100, 1-12. (Pubitemid 32057801)
25. Hnia, K., Gayraud, J., Hugon, G., Ramonatxo, M., De La Porte, S., Matecki, S., Mornet, D., 2008. L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers. Am. J. Pathol. 172, 1509-1519. (Pubitemid 351793345)
26. Hodgetts, S., Radley, H., Davies, M., Grounds, M.D., 2006. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFαlpha function with Etanercept in mdx mice. Neuromuscular Disord. 16, 591-602. (Pubitemid 44374323)
27. Lesault, P.F., Theret, M., Magnan, M., Cuvellier, S., Niu, Y., Gherardi, R.K., Tremblay, J.P., Hittinger, L., Chazaud, B., 2012. Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into mdx skeletal muscle. PloS One 7, e46698.
28. Mantovani, A., Biswas, S.K., Galdiero, M.R., Sica, A., Locati, M., 2013. Macrophage plasticity and polarization in tissue repair and remodeling. J. Pathol. 229, 176-185.
29. Marques, M.J., Luz, M.A., Minatel, E., Neto, H.S., 2005. Muscle regeneration in dystrophic mdx mice is enhanced by isosorbide dinitrate. Neurosci. Lett. 382, 342-345. (Pubitemid 40733649)
30. Martinez, F.O., Gordon, S., Locati, M., Mantovani, A., 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311. (Pubitemid 44715100)
31. McCafferty, D.M., Mudgett, J.S., Swain, M.G., Kubes, P., 1997. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenter-ology 112, 1022-1027. (Pubitemid 27113830)
32. Messin, R., Bruhwyler, J., Dubois, C., Famaey, J.P., Geczy, J., 2006. Tolerability to 1-year treatment with once-daily molsidomine in patients with stable angina. Adv. Ther. 23, 601-614. (Pubitemid 44747440)
33. Mosser, D.M., Edwards, J.P., 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
34. Nagy, G., Clark, J.M., Buzas, E.I., Gorman, C.L., Cope, A.P., 2007. Nitric oxide, chronic inflammation and autoimmunity. Immunol. Lett. 111, 1-5. (Pubitemid 47017476)
35. Nguyen, H.X., Tidball, J.G., 2003. Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice. J. Physiol. 550, 347-356. (Pubitemid 36889296)
36. Noack, E., Feelisch, M., 1989. Molecular aspects underlying the vasodilator action of molsidomine. J. Cardiovasc. Pharmacol. 14 (Suppl. 11), S1-S5. (Pubitemid 20313483)
37. Rigamonti, E., Touvier, T., Clementi, E., Manfredi, A.A., Brunelli, S., Rovere-Querini, P., 2013. Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage. J. Immunol. 190, 1767-1777.
38. Sciorati, C., Buono, R., Azzoni, E., Casati, S., Ciuffreda, P., D'Angelo, G., Cattaneo, D., Brunelli, S., Clementi, E., 2010. Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans. Br. J. Pharmacol. 160, 1550-1560.
39. Sciorati, C., Miglietta, D., Buono, R., Pisa, V., Cattaneo, D., Azzoni, E., Brunelli, S., Clementi, E., 2011. A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy. Pharmacol. Res. 64, 210-217.
40. Sciorati, C., Touvier, T., Buono, R., Pessina, P., François, S., Perrotta, C., Meneveri, R., Clementi, E., Brunelli, S., 2009. Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting. J. Cell Sci. 122, 1119-1125.
41. Tidball, J.G., 2005. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R345-R353. (Pubitemid 40129595)
42. Tidball, J.G., Villalta, S.A., 2010. Regulatory interactions between muscle and the immune system during muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1173-R1187.
43. Tripathi, P., Kashyap, L., Singh, V., 2007. The role of nitric oxide in inflammatory reactions. FEMS Immunol. Med. Microbiol. 51, 443-452. (Pubitemid 350076162)
44. Villalta, S.A., Deng, B., Rinaldi, C., Wehling-Henricks, M., Tidball, J.G., 2011a. IFN-gamma promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. J. Immunol. 187, 5419-5428.
45. Villalta, S.A., Rinaldi, C., Deng, B., Liu, G., Fedor, B., Tidball, J.G., 2011b. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum. Mol. Genet. 20, 790-805.
46. Voisin, V., Sebrie, C., Matecki, S., Yu, H., Gillet, B., Ramonatxo, M., Israel, M., De la Porte, S., 2005. L-arginine improves dystrophic phenotype in mdx mice. Neurobiol. Dis. 20, 123-130. (Pubitemid 41219209)
47. Wahl, S.M., McCartney-Francis, N., Chan, J., Dionne, R., Ta, L., Orenstein, J.M., 2003. Nitric oxide in experimental joint inflammation. Benefit or detriment? Cells Tissues Organs 174, 26-33. (Pubitemid 36677091)
48. Wang, G., Burczynski, F.J., Hasinoff, B.B., Zhang, K., Lu, Q., Anderson, J.E., 2009. Development of a nitric oxide-releasing analogue of the muscle relaxant guaifenesin for skeletal muscle satellite cell myogenesis. Mol. Pharm. 6, 895-904.
49. Wehling, M., Spencer, M.J., Tidball, J.G., 2001. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol. 155, 123-131. (Pubitemid 34286213)
50. Wehling-Henricks, M., Tidball, J.G., 2011. Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane. PloS One 6, e25071.